Endemic acinetobacter baumannii in a New York hospital

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Weisenberg, Scott A ^a   Schuetz, Audrey N ^a   Alexander, Elizabeth A ^a   Eiss, Brain ^a   Behta, Maryam ^b   Saiman, Lisa ^c,d   Larone, Davise H ^a   Jenkins, Stephen G ^a   Rhee, Kyu Y ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b PRESBYTERIAN HEALTHCARE   (United States)

^c Howard Hughes Medical Institute   (United States)

^d NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFEPIME; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; POLYMYXIN B; SULTAMICILLIN; TIGECYCLINE; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; ENDEMIC DISEASE; FEMALE; GENETIC ASSOCIATION; GEOGRAPHIC DISTRIBUTION; HOSPITAL; HUMAN; INTEGRON; MALE; METABOLOMICS; MOLECULAR EPIDEMIOLOGY; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREVALENCE; REPEAT PROCEDURE; SCHOOL CHILD; SEQUENCE HOMOLOGY; STRAIN DIFFERENCE; UNITED STATES; CROSS INFECTION; DRUG EFFECT; GENETICS; METABOLISM; METABOLOME; MICROBIOLOGY; PATHOGENICITY;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; CROSS INFECTION; ENDEMIC DISEASES; HOSPITALS; HUMANS; INTEGRONS; METABOLOME; MOLECULAR EPIDEMIOLOGY; NEW YORK CITY;

EID: 83255192958     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028566     Document Type: Article

References (31)

1. Peleg A, Seifert H, Paterson D, (2008) Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 21: 538-582.
2. Gaynes R, Edwards J, (2005) Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 41: 848-854.
3. Talbot G, Bradley J, Edwards JJ, Gilbert D, Scheld M, et al. (2006) Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis 42: 657-668.
4. Morgan D, Weisenberg S, Augenbraun M, Calfee D, Currie B, et al. (2009) Multidrug-resistant Acinetobacter baumannii in New York City- 10 years into the epidemic. Infect Control Hosp Epidemiol 30: 196-197.
5. Lévesque C, Piché L, Larose C, Roy P, (1995) PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob Agents Chemother 39: 185-191.
6. Martinez-Freijo P, Fluit A, Schmitz F, Grek V, Verhoef J, et al. (1998) Class I integrons in Gram-negative isolates from different European hospitals and association with decreased susceptibility to multiple antibiotic compounds. J Antimicrob Chemother 42: 689-696.
7. Barlow R, Pemberton J, Desmarchelier P, Gobius K, (2004) Isolation and characterization of integron-containing bacteria without antibiotic selection. Antimicrob Agents Chemother 48: 838-842.
8. Turton J, Woodford N, Glover J, Yarde S, Kaufmann M, et al. (2006) Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol 44: 2974-2976.
9. Saeed S, Fakih M, Riederer K, Shah A, Khatib R, (2006) Interinstitutional and intrainstitutional transmission of a strain of Acinetobacter baumannii detected by molecular analysis: comparison of pulsed-field gel electrophoresis and repetitive sequence-based polymerase chain reaction. Infect Control Hosp Epidemiol 27: 981-983.
10. Tomaras A, Flagler M, Dorsey C, Gaddy J, Actis L, (2008) Characterization of a two-component regulatory system from Acinetobacter baumannii that controls biofilm formation and cellular morphology. Microbiology 154: 3398-3409.
11. Brauer M, Yuan J, Bennett B, Lu W, Kimball E, et al. (2006) Conservation of the metabolomic response to starvation across two divergent microbes. Proc Natl Acad Sci U S A 103: 19302-19307.
12. Weisenberg S, Butterfield T, Fischer S, Rhee K, (2009) Suitability of silica hydride stationary phase, aqueous normal phase chromatography for untargeted metabolomic profiling of Enterococcus faecium and Staphylococcus aureus. J Sep Sci 32: 2262-2265.
13. Bradford M, (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
14. Sana T, Roark J, Li X, Waddell K, Fischer S, (2008) Molecular formula and METLIN Personal Metabolite Database matching applied to the identification of compounds generated by LC/TOF-MS. J Biomol Tech 19: 258-266.
15. Higgins P, Dammhayn C, Hackel M, Seifert H, (2010) Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother 65: 233-238.
16. Juni E, (1978) Genetics and physiology of Acinetobacter. Annu Rev Microbiol 32: 349-371.
17. Jones R, Deshpande L, Fritsche T, Sader H, (2004) Determination of epidemic clonality among multidrug-resistant strains of Acinetobacter spp. and Pseudomonas aeruginosa in the MYSTIC Programme (USA, 1999-2003). Diagn Microbiol Infect Dis 49: 211-216.
18. Quale J, Bratu S, Landman D, Heddurshetti R, (2003) Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City. Clin Infect Dis 37: 214-220.
19. Landman D, Butnariu M, Bratu S, Quale J, (2009) Genetic relatedness of multidrug-resistant Acinetobacter baumannii endemic to New York City. Epidemiol Infect 137: 174-180.
20. Landman D, Bratu S, Kochar S, Panwar M, Trehan M, et al. (2007) Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY. J Antimicrob Chemother 60: 78-82.
21. Baang JH, Axelrod P, Decker BK, Hujer AM, Dash G, et al. (2011) Longitudinal epidemiology of multidrug-resistant (MDR) Acinetobacter species in a tertiary care hospital. Am J Infect Control.
22. Runnegar N, Sidjabat H, Goh HM, Nimmo GR, Schembri MA, et al. (2010) Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a single institution over a 10-year period. J Clin Microbiol 48: 4051-4056.
23. Lee Y, Huang L, Chen T, Siu L, Fung C, et al. (2009) Gene cassette arrays, antibiotic susceptibilities, and clinical characteristics of Acinetobacter baumannii bacteremic strains harboring class 1 integrons. J Microbiol Immunol Infect 42: 210-219.
24. Huang L, Chen T, Lu P, Tsai C, Cho W, et al. (2008) Dissemination of multidrug-resistant, class 1 integron-carrying Acinetobacter baumannii isolates in Taiwan. Clin Microbiol Infect 14: 1010-1019.
25. Oh J, Kim K, Jeong Y, Cho J, Park J, et al. (2002) Epidemiological typing and prevalence of integrons in multiresistant Acinetobacter strains. APMIS 110: 247-252.
26. Gordon N, Wareham D, (2010) Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance. Int J Antimicrob Agents 35: 219-226.
27. Fournier P, Vallenet D, Barbe V, Audic S, Ogata H, et al. (2006) Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet 2: e7.
28. Jawad A, Seifert H, Snelling A, Heritage J, Hawkey P, (1998) Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates. J Clin Microbiol 36: 1938-1941.
29. Rodríguez-Baño J, Cisneros J, Fernández-Cuenca F, Ribera A, Vila J, et al. (2004) Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitals. Infect Control Hosp Epidemiol 25: 819-824.
30. Soares N, Cabral M, Gayoso M, Mallo S, Rodriguez-Velo P, et al. (2010) Associating growth-phase-related changes in the proteome of Acinetobacter baumannii with increased resistance to oxidative stress. J Proteome Res.
31. Kim HU, Kim TY, Lee SY, (2010) Genome-scale metabolic network analysis and drug targeting of multi-drug resistant pathogen Acinetobacter baumannii AYE. Mol Biosyst 6: 339-348.